These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 919129)
21. Urolithiasis in rats with diabetes insipidus (Brattleboro strain rats). Kinter LB; McDonald J; Beeuwkes R; Gittes R J Urol; 1982 Nov; 128(5):1077-80. PubMed ID: 7176037 [TBL] [Abstract][Full Text] [Related]
22. Studies of bladder stone disease in Thailand. XI. Effect of 4-hydroxy-L-proline and orthophosphate supplementations on crystalluria. Dhanamitta S; Valyasevi A; Van Reen R Am J Clin Nutr; 1970 Mar; 23(3):371-6. PubMed ID: 5436643 [No Abstract] [Full Text] [Related]
23. Symposium on renal lithiasis. Medical aspects of renal calculous disease. Treatment and prophylaxis. Thomas WC Urol Clin North Am; 1974 Jun; 1(2):261-78. PubMed ID: 4610943 [No Abstract] [Full Text] [Related]
24. A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis. Williams JJ; Rodman JS; Peterson CM N Engl J Med; 1984 Sep; 311(12):760-4. PubMed ID: 6472365 [TBL] [Abstract][Full Text] [Related]
25. Adherence of urease-induced crystals to rat bladder epithelium. Grenabo L; Hedelin H; Pettersson S Urol Res; 1988; 16(1):49-52. PubMed ID: 3344564 [TBL] [Abstract][Full Text] [Related]
26. Adjunctive chemotherapy of infection-induced staghorn calculi. Griffith DP; Moskowitz PA; Carlton CE Trans Am Assoc Genitourin Surg; 1978; 70():25-9. PubMed ID: 380109 [TBL] [Abstract][Full Text] [Related]
27. Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi. Griffith DP; Gibson JR; Clinton CW; Musher DM J Urol; 1978 Jan; 119(1):9-15. PubMed ID: 23442 [TBL] [Abstract][Full Text] [Related]
29. Preventive effect of some substances on experimental oxalic calculogenesis in the frog. Sorrentino F; Fella A; Pota A Urol Res; 1981; 9(2):63-6. PubMed ID: 6972114 [TBL] [Abstract][Full Text] [Related]
30. Ureaplasma-urealyticum-induced bladder stones in rats and their prevention by flurofamide and doxycycline. Texier-Maugein J; Clerc M; Vekris A; Bebear C Isr J Med Sci; 1987 Jun; 23(6):565-7. PubMed ID: 3667226 [TBL] [Abstract][Full Text] [Related]
34. Benurestat, a urease inhibitor for the therapy of infected ureolysis. Andersen JA Invest Urol; 1975 Mar; 12(5):381-6. PubMed ID: 1089613 [TBL] [Abstract][Full Text] [Related]
35. Re: Reduction of infection stones in rats by combined antibiotic and phosphocitrate therapy. Roberts JA J Urol; 1990 Jan; 143(1):135. PubMed ID: 2294245 [No Abstract] [Full Text] [Related]
36. Evaluation of effects of novel urease inhibitor, N-(pivaloyl)glycinohydroxamic acid on the formation of an infection bladder stone using a newly designed urolithiasis model in rats. Satoh M; Munakata K; Takeuchi H; Yoshida O; Takebe S; Kobashi K Chem Pharm Bull (Tokyo); 1991 Apr; 39(4):894-6. PubMed ID: 1893494 [TBL] [Abstract][Full Text] [Related]
37. Acetohydroxamate in struvite stones: in vivo study. Aroldi A; Graziani G; Castelnovo C; Colussi G; Surian M; Mandressi A; Mascheroni E; Pazardjiklian I; Pagano A; Ponticelli C Proc Eur Dial Transplant Assoc; 1983; 20():469-72. PubMed ID: 6657671 [TBL] [Abstract][Full Text] [Related]
39. Clinical experience with low dosage of propionohydroxamic acid (PHA) in infected renal stones. Martelli A; Buli P; Spatafora S Urology; 1986 Nov; 28(5):373-5. PubMed ID: 3787895 [TBL] [Abstract][Full Text] [Related]
40. Effect of estrogen on the formation of struvite calculi in female rats. Matsushita K Urol Int; 1984; 39(5):303-7. PubMed ID: 6506366 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]